Carim V. Khouzami - Apr 1, 2024 Form 4 Insider Report for EXELON CORP (EXC)

Role
CEO of BGE
Signature
Melissa E Ramirez, attorney-in-fact for Carim V Khouzami
Stock symbol
EXC
Transactions as of
Apr 1, 2024
Transactions value $
$0
Form type
4
Date filed
4/26/2024, 04:18 PM
Previous filing
Jan 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding EXC Common Stock 16,405 Apr 1, 2024 Direct
holding EXC Common Stock 401k 8,834 Apr 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EXC 2024 Restricted Stock Units 7,801 Apr 1, 2024 Common Stock 7,801 Direct F1
holding EXC 2023 Restricted Stock Units 4,549 Apr 1, 2024 Common Stock 4,549 Direct F1
holding EXC 2022 Restricted Stock Units 2,276 Apr 1, 2024 Common Stock 2,275 Direct F1
holding EXC Deferred phantom share equivalents 766 Apr 1, 2024 Common Stock 766 Direct F2

Carim V. Khouzami is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Restricted stock unit (RSU) award granted under the Exelon LTIP. Award vests in 1/3 increments at the January or February meeting of the Exelon Comp. Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award.
F2 Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.

Remarks:

The Board of Directors of Exelon has determined that, as of April 1, 2024, Mr. Khouzami is no longer subject to the reporting provisions of Section 16 of the Securities Exchange Act of 1934. Mr. Khouzami is and will remain an officer of Exelon and continue to perform his duties as the CEO of BGE. This form is being filed solely to indicate that Mr. Khouzami is no longer covered by the reporting system and is no longer subject to the reporting requirements of Section 16 with respect to Exelon securities.